These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 30686681

  • 1. Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients.
    Nam BD, Kim TJ, Park K, Ahn MJ, Choi YL, Chung MJ, Kim TS, Lee KS.
    Clin Lung Cancer; 2019 May; 20(3):e309-e316. PubMed ID: 30686681
    [Abstract] [Full Text] [Related]

  • 2. Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.
    Kim H, Chae KJ, Yoon SH, Kim M, Keam B, Kim TM, Kim DW, Goo JM, Park CM.
    Eur Radiol; 2018 Feb; 28(2):861-868. PubMed ID: 28786010
    [Abstract] [Full Text] [Related]

  • 3. The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M.
    Tseng JS, Su KY, Yang TY, Chen KC, Hsu KH, Chen HY, Tsai CR, Yu SL, Chang GC.
    Oncotarget; 2016 Jul 26; 7(30):48059-48069. PubMed ID: 27384480
    [Abstract] [Full Text] [Related]

  • 4. Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting.
    Nam Y, Kim HC, Kim YC, Jang SH, Lee KY, Lee SY, Lee SH, Lee SY, Yoon SH, Ryu JS, Jang TW, Chang YS, Kim SJ, Park CK, Lee JE, Jung CY, Choi CM.
    Thorac Cancer; 2021 Mar 26; 12(6):890-898. PubMed ID: 33529490
    [Abstract] [Full Text] [Related]

  • 5. Non-Small Cell Lung Cancer with Resistance to EGFR-TKI Therapy: CT Characteristics of T790M Mutation-positive Cancer.
    Koo HJ, Kim MY, Park S, Lee HN, Kim HJ, Lee JC, Kim SW, Lee DH, Choi CM.
    Radiology; 2018 Oct 26; 289(1):227-237. PubMed ID: 30015588
    [Abstract] [Full Text] [Related]

  • 6. Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography.
    Li M, Zhang L, Tang W, Jin YJ, Qi LL, Wu N.
    Eur Radiol; 2019 Jun 26; 29(6):2989-2997. PubMed ID: 30367185
    [Abstract] [Full Text] [Related]

  • 7. [Relationship between EGFR Mutations and Pathological Classification and 
Specimen of Lung Adenocarcinoma].
    Kang L, Zheng J, Zhu X.
    Zhongguo Fei Ai Za Zhi; 2017 Jun 20; 20(6):382-388. PubMed ID: 28641695
    [Abstract] [Full Text] [Related]

  • 8. Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer.
    Kawamura T, Kenmotsu H, Omori S, Nakashima K, Wakuda K, Ono A, Naito T, Murakami H, Omae K, Mori K, Tanigawara Y, Nakajima T, Ohde Y, Endo M, Takahashi T.
    Clin Lung Cancer; 2018 Mar 20; 19(2):e247-e252. PubMed ID: 28866043
    [Abstract] [Full Text] [Related]

  • 9. Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.
    Schneider F, Smith MA, Lane MC, Pantanowitz L, Dacic S, Ohori NP.
    Am J Clin Pathol; 2015 Feb 20; 143(2):193-200; quiz 306. PubMed ID: 25596245
    [Abstract] [Full Text] [Related]

  • 10. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.
    Sánchez-Font A, Chalela R, Martín-Ontiyuelo C, Albero-González R, Dalmases A, Longarón R, Alonso-Espinaco V, Curull V, Bellosillo B, Pijuan L.
    Cancer Cytopathol; 2018 Oct 20; 126(10):860-871. PubMed ID: 30291816
    [Abstract] [Full Text] [Related]

  • 11. Standardized uptake value on (18)F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs.
    Yoshida T, Tanaka H, Kuroda H, Shimizu J, Horio Y, Sakao Y, Inaba Y, Iwata H, Hida T, Yatabe Y.
    Lung Cancer; 2016 Oct 20; 100():14-19. PubMed ID: 27597275
    [Abstract] [Full Text] [Related]

  • 12. Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Cao Y, Xu H, Liao M, Qu Y, Xu L, Zhu D, Wang B, Tian S.
    Int J Clin Oncol; 2018 Apr 20; 23(2):249-257. PubMed ID: 28988295
    [Abstract] [Full Text] [Related]

  • 13. CT-guided transthoracic needle biopsy: advantages in histopathological and molecular tests.
    Porrello C, Gullo R, Gagliardo CM, Vaglica A, Palazzolo M, Giangregorio F, Iadicola D, Catanzaro A, Scerrino G, Lo Faso F, Carini F, Tomasello G.
    Future Oncol; 2020 Jun 20; 16(16s):27-32. PubMed ID: 31596139
    [Abstract] [Full Text] [Related]

  • 14. EGFR, KRAS, BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies.
    Forest F, Stachowicz ML, Casteillo F, Karpathiou G, Gouzy-Grosjean F, Guilaubey C, Cottier M, Beal J, Clemenson A, Péoc'h M.
    Exp Mol Pathol; 2017 Dec 20; 103(3):306-310. PubMed ID: 29175303
    [Abstract] [Full Text] [Related]

  • 15. Utility of Core Biopsy Specimen to Identify Histologic Subtype and Predict Outcome for Lung Adenocarcinoma.
    Kim TH, Buonocore D, Petre EN, Durack JC, Maybody M, Johnston RP, Travis WD, Adusumilli PS, Solomon SB, Ziv E.
    Ann Thorac Surg; 2019 Aug 20; 108(2):392-398. PubMed ID: 30986416
    [Abstract] [Full Text] [Related]

  • 16. Suitability of computed tomography-guided biopsy specimens for subtyping and genotyping of non-small-cell lung cancer.
    Hsiao SH, Chung CL, Lee CM, Chen WY, Chou YT, Wu ZH, Chen YC, Lin SE.
    Clin Lung Cancer; 2013 Nov 20; 14(6):719-25. PubMed ID: 23891241
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma.
    Mohar B, Smojver Ježek S, Rajković Molek K, Štemberger C, Kurpis M, Kupanovac Ž, Samaržija M, Jonjić N, Grahovac B.
    Cytopathology; 2016 Dec 20; 27(6):444-451. PubMed ID: 26990359
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.